Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest updates to the Moderna Press Releases page
- Check5 days agoChange DetectedStock price and trading volume on the page were updated from $52.87 and 3.18M to $55.80 and 4.57M.SummaryDifference0.9%
- Check13 days agoChange DetectedAdded new press release entries: Moderna Resolves Global Patent Litigation with Arbutus/Genevant (March 3, 2026) and EMA positive opinion for mCOMBRIAX (February 27, 2026). Updated stock data show $52.87 with 3.18M volume.SummaryDifference5%
- Check20 days agoChange DetectedStock price and volume in the header were updated from $43.93 / 10.45M to $50.52 / 7.01M.SummaryDifference2%
- Check27 days agoChange DetectedNew press releases and headlines with dates were added to the News and Blog Posts page, expanding coverage of Moderna’s corporate updates, conferences, collaborations, and financial results. Stock price and trading volume indicators in the header were updated to reflect current market data.SummaryDifference7%
- Check34 days agoChange DetectedStock price and volume display added ($41.99, 9.99M); several older press releases were removed from the News and Blog Posts list.SummaryDifference4%
- Check41 days agoChange DetectedAdded a new press release about the Recordati collaboration for mRNA-3927 and announced Dr. David Berman as Chief Development Officer (Jan 29–30, 2026). Updated stock quote data from $45.45/15.26M to $42.20/9.37M.SummaryDifference2%
Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.